Workflow
大豆分离蛋白
icon
Search documents
向百亿级食品产业集群迈进
Xin Lang Cai Jing· 2026-01-13 22:55
(来源:黑龙江日报) 黑龙江梅里斯经济开发区是一个以食品加工为主的专业园区。为打造"成本洼地"与"价值高地",开发区 累计投入资金3.73亿元,建成5栋标准化车间及配套办公用房,引进九洲集团提供能源支持,招来中 塑、容大两家包装企业和领航物流提供配套服务,初步形成"产业园就是产业链,前后楼就是上下游"的 发展格局。截至目前,开发区已成功招引24家加工企业入驻,其中投产20家,培育规上工业企业6家, 正逐步成为区域食品产业发展的集聚平台。 当地聚焦新兴领域党建特点,创新打造党建指导员队伍,将全会精神落实到开发区的每个企业。龙记珍 牛农牧集团总经理刘兰晶说:"《中共中央关于制定国民经济和社会发展第十五个五年规划的建议》中 指出要把农业建成现代化大产业。像我们这样的涉农产业迎来了快速发展的机遇。" □张振翼 本报记者 孙昊 梅里斯达斡尔族区这种贯通全产业链的低成本、高效率产业发展模式,不仅扩大了以商招商"朋友圈", 也有效促进了现有企业增资裂变、扩产增能。2023年落户于此的中蓝食品相继建成油炸薯条、速冻南瓜 和速冻蔬菜3条生产线,并即将建设20万立方米智能冷藏库及物流配送项目,将具备年产3万吨速冻蔬菜 的加工能力 ...
索宝蛋白(603231):全产业链布局驱动增长 成本利好大豆蛋白龙头迎业绩拐点
Xin Lang Cai Jing· 2026-01-12 00:30
Core Viewpoint - The company, a leading player in the domestic soybean protein industry, is experiencing a performance turning point due to its full industry chain layout and favorable cost conditions, focusing on non-GMO soybean products [1][2]. Group 1: Company Performance - The company specializes in the full industry chain of non-GMO soybeans, with main products including soybean isolate protein, concentrate protein, textured protein, and non-GMO soybean oil [1]. - In 2025, the company is expected to see a performance turnaround, with Q1-Q3 revenue reaching 1.24 billion yuan, a year-on-year increase of 7.37%, and net profit attributable to shareholders of 147 million yuan, a year-on-year increase of 60% [1]. - The company has actively expanded production to increase sales, and as downstream demand gradually recovers, it anticipates improved financial performance [1]. Group 2: Industry Dynamics - The demand for soybean protein is rapidly growing, driven by health and environmental concerns, with applications in meat processing, plant-based meat, snacks, and health products [1]. - China holds approximately 50% of the global soybean protein market, with the industry size reaching 14.52 billion yuan in 2022, and a CAGR of 3.89% from 2018 to 2022 [1]. - The industry concentration is expected to increase, with the top five companies holding a market share of 60%, and the company itself holding about 10% market share [1]. Group 3: Competitive Advantages - The company has established a high-profit barrier through its full industry chain layout and has a complete product line in soybean protein deep processing, which enhances its competitive advantage [2]. - The company's gross profit margin for soybean protein is significantly higher than the industry average, supported by a focus on high-margin products like soybean concentrate protein and textured protein [2]. - The company has procured a significant amount of low-cost soybean raw materials in early 2025, which, combined with product structure optimization, is expected to enhance its gross profit margin [2]. Group 4: Financial Projections - Revenue projections for the company from 2025 to 2027 are estimated at 1.658 billion yuan, 1.881 billion yuan, and 2.136 billion yuan, representing year-on-year growth of 6.57%, 13.50%, and 13.54% respectively [2]. - Net profit projections for the same period are expected to be 186 million yuan, 215 million yuan, and 266 million yuan, with year-on-year growth of 53.46%, 15.81%, and 23.56% respectively [2].
永远的铁道兵不朽的创业魂——追记香驰控股原董事长刘连民
Qi Lu Wan Bao· 2026-01-09 02:17
Core Viewpoint - Liu Lianmin, the founder and chairman of Xiangchi Holdings, passed away at the age of 69, leaving behind a legacy of dedication to the grain and oil processing industry, transforming a small plant into a leading enterprise in deep processing of soybeans and corn in China [1][10]. Group 1: Early Life and Military Service - Liu Lianmin was born in 1957 in a farming family in Boxin County and became a soldier in the railway troops, where he demonstrated exceptional work ethic by exceeding daily tasks [2][3]. - His military service instilled in him a strong sense of resilience and dedication, earning him multiple awards and recognition during his time in the army [3]. Group 2: Career Development - After retiring from the military, Liu was appointed as the manager of the local grain depot, where he quickly rose through the ranks due to his hard work and innovative approach [3][4]. - In 1989, he took on the role of factory director at the Boxin County Plant Oil Factory, facing significant challenges but responding with a commitment to improve management and production processes [4][5]. Group 3: Business Growth and Achievements - Under Liu's leadership, the plant achieved national quality standards within six months and expanded its product offerings, including soy sauce and vinegar, leading to significant revenue growth [5][6]. - By 1994, the plant became the top in Shandong Province with sales revenue of 73.23 million yuan and continued to grow, eventually transforming into Xiangchi Grain and Oil Company [6][10]. Group 4: Strategic Innovations - Liu recognized the need for strategic transformation in response to market changes, leading to the development of high-value-added products and establishing a circular economy model within the company [7][8]. - The company became a leader in the domestic soybean protein industry, with exports accounting for 20% of the national total and a market share of over 60% in high-end nutritional protein [8][10]. Group 5: Social Responsibility and Legacy - Liu emphasized the importance of giving back to society, contributing over 20 million yuan to various charitable causes and supporting education initiatives in underprivileged areas [13]. - His commitment to employee welfare and community support fostered a strong corporate culture, which continues to influence the company even after his passing [12][13].
“双源供给”竞争 大豆精深加工促产业链升级
Sou Hu Cai Jing· 2025-11-25 15:16
Core Insights - The domestic soybean industry is experiencing differentiated competition due to the dual supply of domestic and imported soybeans, alongside an upgrade in the value extraction of domestic soybeans driven by consumption upgrades [1][3]. Group 1: Market Dynamics - A soybean oil pressing factory in Heilongjiang has chosen to halt production for maintenance, as the average price of imported soybeans is around 3900 yuan per ton, which is 100-200 yuan lower than that of domestic high-oil soybeans, and the oil yield from imported soybeans is 2-3 percentage points higher [3]. - In contrast, a deep processing soybean enterprise in Yucheng, Shandong, is experiencing a production peak, with products including soybean protein isolate, plant-based meat, and functional beverages, targeting markets that imported soybeans cannot easily replace [5]. Group 2: Procurement and Production Trends - The Yucheng soybean processing company has procured over 50,000 tons of new season soybeans, with over 30% being high-protein soybeans, marking a year-on-year increase of approximately 15% [7]. - A new soybean protein deep processing plant is under construction in Heilongjiang, expected to be operational by the end of the year, with an annual processing capacity of 150,000 tons of domestic soybeans [9]. Group 3: Product Development and Market Potential - The focus is on creating high-end differentiated soybean protein products, which can reach prices of 25,000 to 30,000 yuan per ton in applications such as health foods, special medical foods, infant foods, and elderly foods [11]. - Customs data indicates that from January to October 2025, China imported 95.682 million tons of soybeans, a year-on-year increase of 6.4%, suggesting a steady rise in overall demand for soybeans as the industry chain continues to extend [13]. Group 4: Future Outlook - The domestic soybean industry is expected to avoid homogenized competition with imported soybeans by leveraging the unique advantages of high-protein domestic soybeans, while also extending the industry chain [17].
索宝蛋白股价连续5天下跌累计跌幅8.35%,国联基金旗下1只基金持2.2万股,浮亏损失4万元
Xin Lang Cai Jing· 2025-11-20 07:27
Core Viewpoint - The stock price of Suobao Protein has been declining for five consecutive days, with a total drop of 8.35% during this period, currently trading at 19.98 CNY per share [1] Company Overview - Suobao Protein Technology Co., Ltd. is located in Ningbo Free Trade Zone, Zhejiang Province, established on October 17, 2003, and listed on December 15, 2023. The company specializes in the research, production, and sales of soybean protein products [1] - The revenue composition of Suobao Protein includes: 32.42% from soybean isolate protein, 20.79% from non-GMO soybean oil, 19.98% from soybean concentrate protein, 17.36% from textured protein, 9.03% from other products, and 0.43% from supplementary products [1] Fund Holdings - Guolian Fund has one fund heavily invested in Suobao Protein. The Guolian Jingsheng One-Year Holding Mixed A Fund (011353) held 22,000 shares in the third quarter, accounting for 0.26% of the fund's net value, ranking as the tenth largest holding. The estimated floating loss today is approximately 7,700 CNY, with a total floating loss of 40,000 CNY during the five-day decline [2] - The Guolian Jingsheng One-Year Holding Mixed A Fund was established on May 14, 2021, with a current size of 144 million CNY. Year-to-date returns are 3.13%, ranking 7,225 out of 8,136 in its category; the one-year return is 5.23%, ranking 6,756 out of 8,055; and the return since inception is 9.07% [2] Fund Manager Information - The fund managers of Guolian Jingsheng One-Year Holding Mixed A Fund are Chen Xinyu, Huo Shunchao, and Ye Tianyang. Chen Xinyu has a tenure of 6 years and 114 days, managing assets totaling 1.211 billion CNY, with the best return of 68.57% and the worst return of -19.21% during his tenure [3] - Huo Shunchao has a tenure of 2 years and 226 days, managing assets of 16.251 billion CNY, with the best return of 30.93% and the worst return of 0.48% [3] - Ye Tianyang has a tenure of 226 days, managing assets of 2.196 billion CNY, with the best return of 2.97% and the worst return of 0.05% [3]
研判2025!中国大豆蛋白行业进入壁垒、市场政策、产业链、市场规模、竞争格局及发展趋势分析:市场需求旺盛[图]
Chan Ye Xin Xi Wang· 2025-11-17 02:00
Core Insights - The plant protein industry, particularly soybean protein, is experiencing rapid growth due to increasing awareness of health and nutrition, with the market size in China projected to reach 16.161 billion yuan in 2024, a year-on-year increase of 4.47% [1][10]. Overview - Protein is essential for life and is composed of amino acids, with 20 types in total. Among these, 8 are essential and must be obtained from food. Plant proteins, particularly from beans, are lower in cholesterol and saturated fats, making them suitable for individuals with liver diseases and for preventing cardiovascular diseases [2][4]. Industry Barriers - The soybean protein industry is subject to strict regulations and quality control measures, including licensing and traceability requirements. New entrants face high technical barriers due to the established production processes and technology of existing players [6][7]. Market Policies - The Chinese government has implemented various policies to enhance soybean self-sufficiency and ensure quality control in soybean protein production. These policies promote the development of the soybean industry and require strict adherence to safety and quality standards [8]. Industry Chain - The soybean protein industry encompasses upstream activities such as soybean cultivation and procurement, midstream production, and downstream applications in various sectors including meat processing, snacks, dairy, and pharmaceuticals. The cost structure indicates that direct materials account for over 60% of production costs, with soybean being the primary raw material [8][9]. Current Development - Soybean is recognized for its high protein content and nutritional value, with various health benefits including cholesterol reduction and improved gut health. The domestic market for soybean protein is maturing rapidly, with significant growth in applications across multiple sectors [10][11]. Competitive Landscape - The soybean protein industry in China has seen the emergence of several key players, including Shandong Yuwang Ecological Food Co., Ltd., and Ningbo Suobao Protein Technology Co., Ltd. These companies are expanding their product offerings and market presence [11][12]. Future Trends - The soybean protein industry is shifting towards high-end products, with increasing production of high-purity and organized proteins. Innovations in processing technologies are expected to enhance the application of soybean protein in emerging fields such as pharmaceuticals and 3D printing [14][15].
索宝蛋白(603231):季度营收提速,盈利继续高增
Investment Rating - The report assigns an "Outperform" rating to the company, with a target price of 26.5 RMB per share based on a 25x PE for 2025E [4][13]. Core Insights - The company has shown steady revenue growth in the first three quarters, with a revenue of 1.24 billion RMB, representing a year-over-year increase of 7.37%. The gross profit margin (GPM) increased by 6.81 percentage points to 17.91%, while the net profit attributable to shareholders grew by 60% to 147 million RMB [4][14]. - In Q3 2025, the company achieved a revenue of 466 million RMB, a significant year-over-year growth of 21.75%, with a GPM of 16.53% [4][15]. - The company is expanding its overseas market presence, with notable cost reduction and efficiency improvements, including the commencement of sales in Singapore [4][16]. Financial Summary - Total revenue projections for 2023A to 2027E are as follows: 1,748 million RMB, 1,555 million RMB, 1,681 million RMB, 1,869 million RMB, and 2,066 million RMB, respectively [2]. - Net profit attributable to shareholders is projected to grow from 146 million RMB in 2023A to 294 million RMB in 2027E, with significant growth rates in the intervening years [2]. - The earnings per share (EPS) forecast for 2025E is 1.06 RMB, increasing to 1.53 RMB by 2027E [4][13].
索宝蛋白统筹国内外市场 第三季度净利润增长135.87%
Zheng Quan Ri Bao Wang· 2025-10-31 12:48
Core Viewpoint - Ningbo Suobao Protein Technology Co., Ltd. reported a significant increase in revenue and net profit for the first three quarters of 2025, indicating strong growth in the soybean protein market driven by rising consumer demand for health and safety in food products [1][2]. Group 1: Financial Performance - The company achieved operating revenue of 1.24 billion yuan, a year-on-year increase of 7.37% [1] - Net profit attributable to shareholders reached 147 million yuan, reflecting a substantial year-on-year growth of 60.00% [1] - In Q3 alone, operating revenue was 466 million yuan, up 21.75% year-on-year, while net profit for the quarter was 49.26 million yuan, marking a remarkable increase of 135.87% [1] Group 2: Business Operations - Suobao Protein specializes in the research, production, and sales of non-GMO soybean protein products, having established a comprehensive deep processing industry chain for non-GMO soybeans [1] - The main products include soybean isolate protein, soybean concentrate protein, textured protein, soybean dietary fiber, and non-GMO soybean oil [1] - The company is actively expanding its international market presence while consolidating its domestic market, enhancing brand recognition and influence [2] Group 3: Industry Trends - There is a growing consumer focus on environmental and health issues, leading to increased demand for organic, green, functional, and health foods globally [1] - Soybean protein is widely used in various sectors, including plant-based meat, meat products, snacks, health products, nutritional supplements, pet food, and bio-fermentation, indicating a broad market development potential [1]
索宝蛋白(603231) - 2025年前三季度主要经营数据公告
2025-10-30 11:28
证券代码:603231 证券简称:索宝蛋白 公告编号:2025-029 宁波索宝蛋白科技股份有限公司 2025年前三季度主要经营数据公告 单位:万元 | 模式 | 2025年1-9月 | | | --- | --- | --- | | | 金额 | 比例 | | 直销 | 74,970.68 | 60.84% | | 经销 | 48,245.26 | 39.16% | | 合计 | 123,215.94 | 100.00% | 单位:万元 项目 2025年1-9月 金额 比例 大豆分离蛋白 36,767.77 29.84% 非转基因大豆油 28,336.59 23.00% 组织化蛋白 20,877.49 16.94% 大豆浓缩蛋白 24,065.47 19.53% 其他产品 13,168.62 10.69% 合计 123,215.94 100.00% 三、按销售区域分类的主营业务销售情况 单位:万元 | 项目 | 2025年1-9月 | | | --- | --- | --- | | | 金额 | 比例 | | 境内 | 77,599.79 | 62.98% | | 境外 | 45,616.15 | 37.0 ...
索宝蛋白10月16日获融资买入1057.08万元,融资余额1.13亿元
Xin Lang Cai Jing· 2025-10-17 01:36
Group 1 - The core viewpoint of the news is that Sobao Protein's stock experienced a decline of 2.52% on October 16, with a trading volume of 57.79 million yuan, indicating market volatility and investor sentiment [1] - As of October 16, Sobao Protein's financing balance reached 113 million yuan, accounting for 5.71% of its circulating market value, which is above the 90th percentile of the past year, suggesting a high level of leverage [1] - The company reported a revenue of 774 million yuan for the first half of 2025, reflecting a year-on-year growth of 0.24%, while the net profit attributable to shareholders increased by 37.62% to 97.43 million yuan [2] Group 2 - Sobao Protein's main business revenue composition includes 32.42% from soybean isolate protein, 20.79% from non-GMO soybean oil, and 19.98% from soybean concentrate protein, indicating a diversified product portfolio [1] - The number of shareholders for Sobao Protein decreased by 3.86% to 19,000 as of September 30, while the average circulating shares per person increased by 4.01% to 5,599 shares [2] - Since its A-share listing, Sobao Protein has distributed a total of 153 million yuan in dividends [3]